MA, F., T, R., M, D., JA, M., VZ, F., Z, K., . . . L, C. (2026). Dose-Response Efficacy and Safety of Factor XI/XIa Inhibitors in Atrial Fibrillation; a Systematic Review and Meta-Analysis With Subgroup Exploration and Trial Sequential Validation. Clinical cardiology, 49(2), e70263. https://doi.org/10.1002/clc.70263
Chicago Style (17th ed.) CitationMA, Faizan, et al. "Dose-Response Efficacy and Safety of Factor XI/XIa Inhibitors in Atrial Fibrillation; a Systematic Review and Meta-Analysis With Subgroup Exploration and Trial Sequential Validation." Clinical Cardiology 49, no. 2 (2026): e70263. https://doi.org/10.1002/clc.70263.
MLA (9th ed.) CitationMA, Faizan, et al. "Dose-Response Efficacy and Safety of Factor XI/XIa Inhibitors in Atrial Fibrillation; a Systematic Review and Meta-Analysis With Subgroup Exploration and Trial Sequential Validation." Clinical Cardiology, vol. 49, no. 2, 2026, p. e70263, https://doi.org/10.1002/clc.70263.